Toni Weinschenk
Inventor
Stats
- 53 US patents issued
- 760 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 53 US Patents Issued
- 760 US Applications Filed
- 982 Total Citation Count
- Nov 21, 2024 Most Recent Filing
- Mar 23, 2004 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
IMMATICS BIOTECHNOLOGIES GMBH | 4
4 1 4 7 8 9 19 6 7 9 6 71 29 | 2004
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 |
MORPHOSYS AG | 1
| 2016
|
Inventor Addresses
Address | Duration |
---|---|
AICHWALD, DE | Oct 19, 17 - Mar 11, 21 |
Aic hwald, DE | Feb 23, 10 - Feb 23, 10 |
Aichwald, DE | Feb 28, 08 - Feb 25, 25 |
Alchwald, DE | Dec 18, 18 - Dec 18, 18 |
ESSLINGEN, DE | Jul 22, 10 - Jul 22, 10 |
Esslingen, DE | Oct 06, 05 - Sep 26, 13 |
Tubingen, DE | Mar 30, 23 - Mar 30, 23 |
Tuebingen, DE | Feb 18, 21 - Mar 25, 25 |
Tuebingen, US | Jun 29, 23 - Jun 29, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 34 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 747 |
A61M: | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY | 13 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12258382 | 2025 | Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers | 0 |
2025/0092,104 | 2025 | IMMUNOTHERAPY WITH A*01 RESTRICTED PEPTIDES AND COMBINATION OF PEPTIDES AGAINST CANCERS AND RELATED METHODS | 0 |
12247057 | 2025 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | 0 |
2025/0074,961 | 2025 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST SMALL CELL LUNG CANCER AND OTHER CANCERS | 0 |
12240877 | 2025 | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.